CA2630497A1 - Compositions a base de lipopeptide - Google Patents
Compositions a base de lipopeptide Download PDFInfo
- Publication number
- CA2630497A1 CA2630497A1 CA002630497A CA2630497A CA2630497A1 CA 2630497 A1 CA2630497 A1 CA 2630497A1 CA 002630497 A CA002630497 A CA 002630497A CA 2630497 A CA2630497 A CA 2630497A CA 2630497 A1 CA2630497 A1 CA 2630497A1
- Authority
- CA
- Canada
- Prior art keywords
- amphomycin
- cyclodextrin
- derivatives
- friulimicin
- lipopeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Nanotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005056194.2 | 2005-11-21 | ||
DE102005056194A DE102005056194A1 (de) | 2005-11-21 | 2005-11-21 | Neue Lipopeptid Zusammensetzungen |
PCT/DE2006/002064 WO2007057005A1 (fr) | 2005-11-21 | 2006-11-20 | Compositions a base de lipopeptide |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2630497A1 true CA2630497A1 (fr) | 2007-05-24 |
Family
ID=37763891
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002630497A Abandoned CA2630497A1 (fr) | 2005-11-21 | 2006-11-20 | Compositions a base de lipopeptide |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1951311A1 (fr) |
CN (1) | CN101370524A (fr) |
AU (1) | AU2006314942A1 (fr) |
CA (1) | CA2630497A1 (fr) |
DE (1) | DE102005056194A1 (fr) |
MX (1) | MX2008006476A (fr) |
WO (1) | WO2007057005A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104768966B (zh) * | 2012-09-24 | 2018-11-02 | 中化帝斯曼制药有限公司荷兰公司 | 生产环肽的方法 |
JP2022532045A (ja) * | 2019-05-10 | 2022-07-13 | クセリア ファーマシューティカルズ エーピーエス | ダプトマイシン水性製剤 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4411025A1 (de) * | 1994-03-30 | 1995-10-05 | Hoechst Ag | Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung |
DE19807972A1 (de) * | 1998-02-25 | 1999-08-26 | Hoechst Marion Roussel De Gmbh | Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung |
CA2726789A1 (fr) * | 2000-02-05 | 2001-11-08 | Theravance, Inc. | Preparations antibiotiques a base de glycopeptides contenant des cyclodextrines |
WO2001097851A2 (fr) * | 2000-06-21 | 2001-12-27 | Cubist Pharmaceuticals, Inc. | Compositions et methodes visant a ameliorer l'absorption orale d'agents anti-microbiens |
US7527807B2 (en) * | 2000-06-21 | 2009-05-05 | Cubist Pharmaceuticals, Inc. | Compositions and methods for increasing the oral absorption of antimicrobials |
US6699505B2 (en) * | 2000-10-17 | 2004-03-02 | Massachusetts Institute Of Technology | Method of increasing the efficacy of antibiotics by compexing with cyclodextrins |
-
2005
- 2005-11-21 DE DE102005056194A patent/DE102005056194A1/de not_active Ceased
-
2006
- 2006-11-20 CN CNA2006800511655A patent/CN101370524A/zh active Pending
- 2006-11-20 WO PCT/DE2006/002064 patent/WO2007057005A1/fr active Application Filing
- 2006-11-20 CA CA002630497A patent/CA2630497A1/fr not_active Abandoned
- 2006-11-20 AU AU2006314942A patent/AU2006314942A1/en not_active Abandoned
- 2006-11-20 MX MX2008006476A patent/MX2008006476A/es not_active Application Discontinuation
- 2006-11-20 EP EP06805527A patent/EP1951311A1/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
AU2006314942A1 (en) | 2007-05-24 |
DE102005056194A1 (de) | 2007-07-12 |
MX2008006476A (es) | 2008-09-26 |
EP1951311A1 (fr) | 2008-08-06 |
CN101370524A (zh) | 2009-02-18 |
WO2007057005A1 (fr) | 2007-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1033738C (zh) | 含有粒性的细胞集落刺激因子的稳定药剂及其生产方法 | |
TWI282739B (en) | Pharmaceutical compositions of stabilized botulinum toxin | |
KR101502533B1 (ko) | 우수한 안정성을 갖는 택산 유도체 함유 주사제용동결건조 조성물 및 이의 제조방법 | |
EP2676677B1 (fr) | Préparation pharmaceutique d'anticorps anti-cd40 très concentrée | |
EP0091782B1 (fr) | Composé d'inclusion d'antibiotiques du groupe des Lankacidines et son utilisation | |
CA2026149A1 (fr) | Formules aqueuses stabilisees de peptides a chaines courtes | |
SI9200260A (en) | Lipophilic oligosaccharide antibiotic salt compostition | |
KR100237719B1 (ko) | 플루로머틸린 착체 및 이를 함유하는 약제학적 제제 | |
US7795207B2 (en) | Lipopeptide compositions | |
EP1947094A2 (fr) | Procédé de préparation de dérivés du taxane | |
US20200370025A1 (en) | Acute Respiratory Distress Syndrome Therapeutic Agent | |
EP4014969A1 (fr) | Solution aqueuse | |
PT2047857E (pt) | Agente para fins de injecção compreendendo um antibióitco, e solução para injecção compreendendo o agente | |
WO2017188257A1 (fr) | Polyrotaxane méthylé et procédé pour sa synthèse | |
CN110812334A (zh) | 一种注射用伏立康唑药物组合物及其制备方法 | |
CA2949328C (fr) | Polymyxines faiblement substituees et compositions les comprenant | |
CA2630497A1 (fr) | Compositions a base de lipopeptide | |
EP3777862A1 (fr) | Composition de méloxicam, sa préparation et son procédé de préparation et son utilisation | |
EA018636B1 (ru) | Система доставки лекарственного средства для введения водорастворимого катионного и амфифильного фармацевтически активного вещества | |
EP4014965A1 (fr) | Solution aqueuse | |
CN111465389B (zh) | 多西他赛共缀物的药物组合物及制备方法 | |
CN112999148A (zh) | 复方氨基酸组合物及其制备方法 | |
EP1994938A1 (fr) | Nouvelles compositions de lipoglycodepsipeptide | |
CN1290506C (zh) | 药物组合物 | |
JP2002542201A (ja) | シュードマイシン抗真菌組成物およびその使用方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |